---
title: "Danska börsjättens framgångar ger fart till svensk uppstickare"
type: "Media Coverage"
date: "2026-11-16"
updated: "2026-11-16"
description: "Dagens Industri covers Sigrid’s SEK 44 million financing round and how the success of Danish GLP-1 drugs is drawing attention to Swedish innovation."
url: "https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare"
canonical: "https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare"
markdown_url: "https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare.md"
site: "SiPore"
publisher: "SiPore Technologies (Sigrid Therapeutics AB)"
contact: "contact@sipore.com"
language: "en"
topics:
  - "Financing"
  - "Swedish innovation"
  - "Metabolic health"
outlet: "Dagens Industri"
original_url: "https://www.di.se/nyheter/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare/"
---

# Danska börsjättens framgångar ger fart till svensk uppstickare

*Media Coverage · Nov 16, 2026 · Dagens Industri*

> Dagens Industri covers Sigrid’s SEK 44 million financing round and how the success of Danish GLP-1 drugs is drawing attention to Swedish innovation.

## Coverage

- **Outlet:** Dagens Industri
- **Original article:** [Dagens Industri](https://www.di.se/nyheter/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare/)

Sweden’s leading business daily Dagens Industri reported on Sigrid’s SEK 44 million financing round, linking the momentum to the global success of Danish obesity and diabetes drugs and to growing interest in new Swedish approaches to metabolic health.

## Related articles

- [Ozempic-utmanaren Sigrid Therapeutics backas med 45 miljoner – ska växa i USA](https://sipore.com/insights/ozempic-utmanaren-sigrid-therapeutics-backas-med-45-miljoner-ska-vaxa-i-usa.md) — Media Coverage, 2026-11-16
- [Sigrid Therapeutics utser Claus Kjærsgaard till ny VD](https://sipore.com/insights/sigrid-therapeutics-utser-claus-kjaersgaard-till-ny-vd.md) — Media Coverage, 2026-11-16

## How to cite

SiPore Technologies (Sigrid Therapeutics AB). “Danska börsjättens framgångar ger fart till svensk uppstickare”. SiPore, 2026-11-16. https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare (accessed <date>).

Use the trademarks as written: SiPore®, Carb Fence™. For the SHINE trial, cite the peer-reviewed publication in *eClinicalMedicine* (The Lancet Discovery Science, 2026) rather than this page.

## Company & contact

- **Company:** SiPore Technologies — legal entity Sigrid Therapeutics AB (Swedish org.nr [556958-3023](https://www.allabolag.se/foretag/sigrid-therapeutics-ab/sundbyberg/forskning/2K3ZHRJI5YE3M))
- **Stockholm headquarters:** Vasagatan 14A, 172 61 Sundbyberg, Sweden ([map](https://www.google.com/maps/search/?api=1&query=Vasagatan%2014A%2C%20172%2061%20Sundbyberg%2C%20Sweden))
- **General enquiries:** [contact@sipore.com](mailto:contact@sipore.com)
- **Partnerships & licensing:** [partnerships@sipore.com](mailto:partnerships@sipore.com)
- **Origin:** Founded in Stockholm, Sweden
- **Taglines:** “The meal companion for modern food.” · “Same meal. Less impact.” · “Scandinavian science. Global impact.” · “Precision science for the modern meal.”
- **About:** SiPore® is a patented meal-companion technology designed to reduce the impact of modern meals at the level of digestion.

**Our sites** — all sites owned and operated by Sigrid Therapeutics AB:

- [SiPore.com](https://www.sipore.com/): Technology, science & partnerships
- [SiPorePro.com](https://www.siporepro.com/): Practitioner products & professional resources
- [SigridLife.com](https://sigridlife.com/): SIGRID consumer products
- [SigridStabiliser.se](https://sigridstabiliser.se/): SIGRID Sweden

---
[View on site](https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare) · [All insights](https://sipore.com/insights.md) · [Site index for agents (llms.txt)](https://sipore.com/llms.txt)
